Radiographic and Histological Evaluation of Regenerated Bone After Grafting Using Allograft Shell and Autogenous Chips (Shell grafting)

June 6, 2020 updated by: Khalid Tarek Mohamed Karkar, October 6 University

Evaluation of Anterior Alveolar Ridge Reconstruction With Allogenic Bone Plate and Autogenous Cortical Bone Chips: A Radiographic and Histological Clinical Study

The clinical cases in the present study described the khoury shell technique using an allograft plate and autogenous chips, for horizontal reconstruction of the anterior alveolar ridge in the esthetic zone. Without need to use autogenous bone graft techniques that are characterized by more aggressive surgery.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11566
        • Faculty of Dentistry Ain Shams University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with class IV of Cawood and Howell classification in the anterior maxilla.
  • Males and females 18-50 years of age.
  • Patients with adequate oral hygiene.
  • Patients with healed sites for at least 6 months after tooth extraction.
  • Patients with an inter-arch distance of at least 6 mm.
  • Compliance with all requirements in the study and signing the informed consent.

Exclusion Criteria:

  • Patients with diseases of the immune system or systemic disease affecting bone healing
  • Patients who are chronic users of medications known to affect the periodontal status.
  • Patients with history of intravenous and/or oral bisphosphonate use.
  • Pathologic lesions or acute infection in the area of defect.
  • Patients who are pregnant or lactating mothers.
  • Heavy smokers who smoke more than 10 cigarettes a day.
  • Patients with poor oral hygiene that are not amenable to motivation and improvement.
  • Patients with history of irradiation of the head and neck region.
  • Vulnerable patients.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar Bone quantity
Time Frame: 6 months
Alveolar bone width by millimeters using Cone Beam Computed Tomography
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar Bone quality
Time Frame: 7 months
Histological evaluation of status of regenerated bone vitality and remodeling
7 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2018

Primary Completion (Actual)

July 1, 2019

Study Completion (Actual)

September 5, 2019

Study Registration Dates

First Submitted

March 23, 2020

First Submitted That Met QC Criteria

March 25, 2020

First Posted (Actual)

March 27, 2020

Study Record Updates

Last Update Posted (Actual)

June 9, 2020

Last Update Submitted That Met QC Criteria

June 6, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OMS-2018-03M

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Resorption

Clinical Trials on Horizontal alveolar bone augmentation

3
Subscribe